Clicky

Depression

UM Depression Center to be renamed after Eisenbergs gift $30 million

The University of Michigan has approved the renaming of its depression center in recognition of the Eisenberg family, which has gifted $30 million to fund research on the disease. The UM Depression Center will be known as the Frances and Kenneth Eisenberg and Family Depression Center after the UM board of regents approved the name

UM Depression Center to be renamed after Eisenbergs gift $30 million Read More »

New Efficacy Data on Theta Burst TMS for Bipolar Depression

Despite its proven efficacy for unipolar depression, intermittent theta burst transcranial magnetic stimulation (iTBS) appears to be ineffective in alleviating symptoms of bipolar depression, new research suggests. Overall, investigators found that only 16% of participants responded to iTBS during the double-blind period of the trial, and the proportion of patients who responded to iTBS was

New Efficacy Data on Theta Burst TMS for Bipolar Depression Read More »

Study Sheds Light on Pediatric Depression in Sickle Cell Disease

A new study from Nigeria found that depression in young patients with sickle cell disease (SCD) was linked with increasing age and education level. Led by Osita Uchenna Ezenwosu, PhD, Faculty of Medical Sciences, University of Nigeria, the investigative team conducted a cross-sectional study with adolescents and children with sickle cell anemia (SCA), all of

Study Sheds Light on Pediatric Depression in Sickle Cell Disease Read More »

New Expert Guidance on Ketamine for Resistant Depression

An international panel of mood disorder experts has published guidance on how to safely and effectively use ketamine and esketamine to treat adults with treatment-resistant depression (TRD). “Ketamine and esketamine are the first rapid-onset treatments for adults with TRD, and there was an international need for best-practice guidance on the deft and safe implementation of

New Expert Guidance on Ketamine for Resistant Depression Read More »

Elevated Interleukin-6 During Childhood May be Marker for Psychosis or Depression During Adulthood

Children with elevated interleukin-6 (IL-6) may be at increased risk for psychosis and depression during adulthood. These findings, from a birth cohort study, were published in Schizophrenia Research. Pregnant women (N=14,541) were recruited for the Avon Longitudinal Study of Parents and Children (ALPAC) study in southwest England between 1991 and 1992. IL-6 and C-reactive protein

Elevated Interleukin-6 During Childhood May be Marker for Psychosis or Depression During Adulthood Read More »

California May Launch Its Own Version of the Depression-Era WPA – Next City

Late last year, if you happened to visit San Francisco’s Golden Gate Park, you might have stumbled upon artists on six-foot-tall stilts, sharing reminders of social distancing and mask wearing. Or you might have spotted a musician strumming guitar melodies, accompanied by a woman in a butterfly costume — a “social distance butterfly” out to

California May Launch Its Own Version of the Depression-Era WPA – Next City Read More »

Neuroscience Company Uncloaks to Fight Chronic Pain, Depression and More

Bob Azelby, CEO of Eliem Therapeutics, pictured above. (Doug Pensinger/Getty Images) Eliem Therapeutics emerged from stealth mode with $80 million in financing that will be used to develop therapeutics aimed at treating neuronal excitability disorders such as chronic pain, depression, epilepsy and anxiety. The disorders Eliem is targeting have a wide patient population across the globe.

Neuroscience Company Uncloaks to Fight Chronic Pain, Depression and More Read More »